| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 02/09/2005 | CN1578659A Modulators of peroxisome proliferator activated receptors (ppar) |
| 02/09/2005 | CN1575816A Compounds for the treatment of female sexual dysfunction |
| 02/09/2005 | CN1188418C Cephalosporines having cyclic aminoguanidine substituents as antibiotics |
| 02/09/2005 | CN1188392C Process for synthesis of hydrocarbonfluoride |
| 02/09/2005 | CN1188211C Preparation and use of ionic liquids in microwave-assisted chemical transformation |
| 02/09/2005 | CN1188174C Steam sterilization utilizing water-free hydrogen peroxide source |
| 02/09/2005 | CN1188125C Use of 2-imidazoly substituted carbinols for production of medicament for treatment or prophylaxis of disease states as result of ischaemic conditions |
| 02/08/2005 | US6852761 Inhibitors of serine proteases of the coagulation cascade and compounds, compositions and methods for anticoagulant therapy for the treatment and prevention of a variety of thrombotic conditions including coronary artery and cerebrovascular |
| 02/08/2005 | US6852751 Difluorobutyric acid metalloprotease inhibitors |
| 02/08/2005 | US6852747 Resorcinol derivatives |
| 02/08/2005 | US6852731 3-Substituted-7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; for herpes viruses |
| 02/08/2005 | US6852725 Imidazolyl derivatives |
| 02/08/2005 | US6852711 HIV protease inhibitors |
| 02/08/2005 | CA2265489C Novel cationic oxidation bases, their use for oxidation dyeing of keratin fibres, dyeing compositions and dyeing methods |
| 02/03/2005 | WO2005009974A1 Imidazole compounds and uses thereof |
| 02/03/2005 | WO2005009973A1 5-membered heterocycle-based p38 kinase inhibitors |
| 02/03/2005 | WO2005009941A1 Indane derivates as muscarinic receptor agonists |
| 02/03/2005 | WO2005009940A1 Novel aminobenzophenone compounds |
| 02/03/2005 | WO2005009471A1 Composition for lowering blood-sugar level |
| 02/03/2005 | WO2004106307A3 Novel imidazole derivatives, the production thereof, and the use of the same as a medicament |
| 02/03/2005 | WO2004094384A3 (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer’s disease |
| 02/03/2005 | US20050026983 Imidazole compounds and uses thereof |
| 02/03/2005 | US20050026974 Immunogenic conjugates of nitroaromatic compounds and proteins; monoclonal antibodies specific for nitroaromatic compounds , their protein conjugates |
| 02/03/2005 | US20050026929 2-Phenyl-4-(piperidin-1-ylcarbonyl)-oxazole derivatives; capsase activators; cancer, autoimmune diseases, rheumatoid arthritis, inflammatory bowel disease, or psoriasis |
| 02/03/2005 | US20050026916 Heterocyclic compounds as P2X7 ion channel blockers |
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | US20050026874 Method of use of the compound that includes a conjugated polyene with between 7 to 14 double bonds, and cyclohexene rings with ether, phosphate, sulfate, dextran or other group which imparts water solubility |
| 02/03/2005 | CA2530302A1 Novel aminobenzophenone compounds |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1502914A1 Process for the preparation of 1-amino-4-(hydroxymethyl)-2-cyclopentene derivatives |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501817A1 Imidazolinylmethyl aralkylsulfonamides |
| 02/02/2005 | EP1501810A1 Ionic liquids |
| 02/02/2005 | EP1501806A1 Preparations for the topical application of anti-androgenically active substances |
| 02/02/2005 | EP1501800A1 Bombesin antagonists |
| 02/02/2005 | EP1501790A2 Novel sodium channel blockers |
| 02/02/2005 | EP1501504A1 1-substituted imidazole derivatives as nos inhibitors |
| 02/02/2005 | EP1501467A2 Heterocyclo inhibitors of potassium channel function |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1187363C Covalently linked oligonucleotide minor groove binder conjugates |
| 02/02/2005 | CN1187336C New imidazole derivatives |
| 02/01/2005 | US6849745 Fluorescent dye for use in the detection of preferential compounds |
| 02/01/2005 | US6849741 Method for preparing compounds derived from thiazolidinedione, oxazolidinedione or hydantoin |
| 02/01/2005 | US6849739 N-heterocyclic derivatives as NOS inhibitors |
| 02/01/2005 | US6849735 Making N-4-carboxyphenyl-3-(6-oxohydropurin-9-yl) propanamide starting from aminopropionic acid, ethyl p-aminobenzoate, and using aminocyanoacetamide |
| 02/01/2005 | US6849733 Compounds containing amidated guanidine derivative type functional group of structure N-C(=N)-N-CO-N-C=N or N-C(=N)-N-CO-N |
| 02/01/2005 | US6849660 Antimicrobial biaryl compounds |
| 02/01/2005 | US6849646 Chromenone and chromanone derivatives as integrin inhibitors |
| 02/01/2005 | US6849634 Potassium channel inhibitors |
| 02/01/2005 | US6849597 Administering a growth hormone secretagogue to a mammal, for preventing nerve cells degeneration or death of neurons |
| 02/01/2005 | US6849097 I.e., N-(thiophen-2 or-3-ylmethyl)-, N-(furan-3-ylmethyl)-, N-(1H-imidazol-2-ylmethyl)- and N-(pyrrol-2-ylmethyl)-p-phenylenediamines; developers for hair dyes |
| 01/27/2005 | WO2005007631A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 01/27/2005 | WO2005007616A1 Diphenylamino ketone derivatives as mek inhibitors |
| 01/27/2005 | WO2005007108A2 Asymmetric disulfides and methods of using same |
| 01/27/2005 | WO2004099130A3 1,2-diarylimidazoles useful as inhibitors of cox |
| 01/27/2005 | US20050020857 Method for the separation of acids from chemical reaction mixtures by means of ionic fluids |
| 01/27/2005 | US20050020849 via non-racemic cinchona-alkaloid-type catalyst (quinidine) for addition of nucleophile |
| 01/27/2005 | US20050020684 Modulators of peroxisome proliferator activated receptors |
| 01/27/2005 | US20050020656 L-histidine, D-histidine, DL-histidine, and/or salts thereof, and optionally cysteine, and/or cystine or salts; fibrosis may be of the kidney, pancreas, lung, vascular vessels, skin, bone marrow, or liver; may be given in foods or beverages |
| 01/27/2005 | US20050020652 For example, 2-(4-{2-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-ethoxy}-2-methyl-phenoxy)-2-methyl-propionic acid, 2-(4-{3-[1-(4-tert-Butyl-benzyl)-3-methyl-2-oxo-imidazolidin-4-yl]-propyl}-2-methyl-phenoky)-2-methyl-propionic acid; for treating diabetes mellitus |
| 01/27/2005 | US20050020648 "PGI2-preferring" (IP) receptors; p-(imidazolin-2-ylamino-optional alkyl)phenyl p'-substituted ethers or sulfides, e.g., 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-phenylsulfanyl)-phenyl]-amine, used to induce hyperalgesia |
| 01/27/2005 | US20050020586 Using 4-imidazoline ester or acid; antiinflammatory agents; microbiocides; bactericides; antitumor agents; autoimmune disease |
| 01/27/2005 | US20050020540 Biphenylcarboxylic amide derivatives as p38-kinase inhibitors |
| 01/27/2005 | US20050020505 Angiogenesis inhibitors; antitumor agents; anticancer agents; atherosclerosis; cardiovascular disorders; antiarthritic agents |
| 01/27/2005 | US20050015898 Hair dyes for keratin fibers |
| 01/27/2005 | CA2573060A1 Asymmetric disulfides and methods of using same |
| 01/27/2005 | CA2532078A1 Naphthylene derivatives as cytochrome p450 inhibitors |
| 01/26/2005 | EP1499898A2 Regulation of tnf-alpha |
| 01/26/2005 | EP1499609A2 Pesticidal heterocycles |
| 01/26/2005 | EP1499608A1 Substituted imidazole derivatives: gaba a receptor ligands |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499591A1 Carboxylic acid amides |
| 01/26/2005 | EP1499583A1 Process for preparing highly functionalized y-butyrolactams and y-amino acids |
| 01/26/2005 | EP1282417B1 Creatinine biosensor |
| 01/26/2005 | EP1082303B1 Heterocyclic derivatives which inhibit factor xa |
| 01/26/2005 | EP0983267B1 Amidoaromatic ring sulfonamide hydroxamic acid compounds |
| 01/26/2005 | CN1571772A Process for distilling alkaline caprolactam product at reduced pressure |
| 01/26/2005 | CN1569841A SARS coronavirus 3CL protease inhibitor and its use |
| 01/26/2005 | CN1569840A Production method and use for imidacloprid artificial hapten, artificial antigen and specific antibody |
| 01/26/2005 | CN1186346C Thienopyrrolidinones |
| 01/26/2005 | CN1186344C Amino acid compounds and use thereof as NEP, ACE and ECE inhibitors |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/25/2005 | US6846958 Synthesis of benzimidate from benzoic acid |
| 01/25/2005 | US6846954 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 01/25/2005 | US6846925 Colchinol derivatives as angiogenesis inhibitors |
| 01/25/2005 | US6846833 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same |
| 01/25/2005 | US6846829 N-heterocyclic derivatives as NOS inhibitors |
| 01/25/2005 | CA2465084C Delivery system and method for delivering a plurality of packages containing a solid material |
| 01/25/2005 | CA2231201C Toilet bowl cleaning tablet |
| 01/25/2005 | CA2129455C Orally active azole derivatives |
| 01/20/2005 | WO2005006352A1 Acid-base mixture and ion conductor composed of such mixture |
| 01/20/2005 | WO2005005452A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005451A1 Specific glucocorticosteroid compound having anti- inflammatory activity |
| 01/20/2005 | WO2005005394A2 Thiophenylaminoimidazolines as prostaglandin i2 antagonists |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2004106411A3 Biodegradable poly(beta-amino esters) and uses thereof |
| 01/20/2005 | WO2004078163A3 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |
| 01/20/2005 | US20050014943 Reacting 5-aminoimidazole-4-carboxamide with triethyl orthoformate; cyclization; hydrolysis |
| 01/20/2005 | US20050014941 Cyanoalkylamino derivatives as protease inhibitors |